Gene therapy for the induction of chimerism and transplant tolerance

Current Gene Therapy

Volumn 7, Issue 6, 2007, Pages 411-420

  Gunthart, Mirja ^a   Kearns Jonker, Mary ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Immunization; MHC class I; Non human primates; Transplant tolerance; Xenotransplantation

Indexed keywords

ALPHA 1,3 GALACTOSYLTRANSFERASE; CYTOKINE; DIHYDROFOLATE REDUCTASE; DIPROTIN A; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOSUPPRESSIVE AGENT; LENTIVIRUS VECTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OKT 4; OKT 8; RETROVIRUS VECTOR; TETRACYCLINE;

ALLOTRANSPLANTATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CHIMERA; DISEASE PREDISPOSITION; DRUG SAFETY; GENE INDUCTION; GENE TRANSFER; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOLOGICAL TOLERANCE; INFECTION; KIDNEY ALLOGRAFT REJECTION; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; ORGAN TRANSPLANTATION; REGULATORY T LYMPHOCYTE; REVIEW; SURVIVAL TIME; VIRAL GENE DELIVERY SYSTEM; VIRAL GENE THERAPY; XENOTRANSPLANTATION;

ANIMALS; GENE THERAPY; HUMANS; TRANSPLANTATION CHIMERA; TRANSPLANTATION TOLERANCE;

PRIMATES;

EID: 37249083498     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652307782793522     Document Type: Review

References (109)

1. Ailles, L., Schmidt, M., Santoni de Sio, F.R., Glimm, H., Cavalieri, S., Bruno, S., Piacibello, W., von Kalle, C., and Naldini, L. (2002). Molecular evidence of lentiviral vector-mediated gene transfer into human self-renewing, multi-potent, long-term NOD/SCID repopulating hematopoietic cells. Mol. Ther., 6(5): 615-626.
2. An, D.S., Kung, S.K.P., Bonifacino, A., Wersto, R.P., Metzger, M.E., Agricola, B.A., Mao, S.H., Chen, I.S.Y., and Donahue, RE. (2001). Lentivirus vector-mediated hematopoietic stem cell gene transfer of common gamma-chain cytokine receptor in rhesus macaques. J. Virol., 75(8): 3547-3555.
3. Anderson, D., Billingham, R.E., Lampkin, G.H., and Medawar, P.B. (1951). The use of skin grafting to distinguish between monozygotic and dizygotic twins in cattle. Heredity, 5: 379.
4. Andersson, G., Illigens, B.M.W., Johnson, K.W., Calderhead, D., LeGuern, C., Benichou, G., White-Scharf, M.E., and Down, J.D. (2003). Non-myeloablative conditioning is sufficient to allow engraftment of EGFP-expressing bone marrow and subsequent acceptance of EGFP-transgenic skin grafts in mice. Blood, 101(11): 4305-4312.
5. Asano, T., Hanazono, Y., Ueda, Y., Muramatsu, S., Kume, A., Suemori, H., Suzuki, Y., Kondo, Y., Harii, K., Hasegawa, M., Nakatsuji, N., and Ozawa, K. (2002). Highly efficient gene transfer into primate embryonic stem cells with a simian lentivirus vector. Mol. Ther. 6(2): 162-168.
6. Bagley, J., Tian, C.R., Sachs, D.H., and Iacomini, J. (2002). Induction of T-cell tolerance to an MHC class I alloantigen by gene therapy. Blood, 99(12): 4394-4399.
7. Barde, I., Zanta-Boussif, M.A., Paisant, S., LeBoeuf, M., Rameau, P., Delenda, C., and Danos, O. (2006). Efficient control of gene expression in the hematopoietic system using a single Tet-on inducible lentiviral vector, Mol. Ther., 13(2): 382-390.
8. Baum, C., Kustikova, O., Modlich, U., Li, Z.X., and Fehse, B. (2006). Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. Hum. Gene Ther., 17(3): 253-263.
9. Bester, A.C., Schwartz, M., Schmidt, M., Garrigue, A., Hacein-Bey-Abina, S., Cavazzana-Calvo, M., Ben-Porat, N., Von Kalle, C., Fischer, A., and Kerem, B. (2006). Fragile sites are preferential targets for integrations of MLV vectors in gene therapy. Gene Ther., 13(13): 1057-1059.
10. Billingham, R.E., Lampkin, G.H., Medawar, P.B., and Williams, H.L.I. (1952). Tolerance to homografts, twin diagnosis, and the freemartin condition in cattle. Heredity, 6: 201
11. Billingham, R.E., Brent, L., and Medawar, P.B. (1953). Actively acquired tolerance of foreign cells. Nature, 172(4379): 603-606.
12. Bracy, J.L., Sachs, D.H., and Iacomini, J. (1998). Inhibition of xenoreactive natural antibody production by retroviral gene therapy. Science, 281: 1845-1847.
13. Bracy, J.L., Chase, C.M., Russell, P.S., Mauiyyedi, S., Colvin, R.B., and Iacomini, J. (2001). Induction of molecular chimerism by gene therapy prevents antibody-mediated heart transplant rejection. Gene Ther., 8(22): 1738-1744.
14. Bühler, L.H., Spitzer, T.R., Sykes, M., Sachs, D.H., Delmonico, F.L., Tolkoff-Rubin, N., Saidman, S.L., Sackstein, R., McAfee, S., Dey, B., Colby, C., and Cosimi, A.B. (2002). Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation, 74(10): 1405-1409.
15. Cavazzana-Calvo,M., Hacein-Bey, S., de Saint Basile, G., Gross, F., Yvon, E., Nusbaum, P., Selz, F., Hue, C., Certain, S., Casanova, J.L., Bousso, P., Le Deist, F., and Fischer, A. (2000). Gene therapy of human severe combined immunodeficiency (SCID).-XI disease. Science, 288(5466): 669-672.
16. Chang, L.J., and Gay, E.E. (2001). The molecular genetics of lentiviral vectors - current and future perspectives. Curr. Gene Ther., 1(3): 237-251.
17. Chen, Z.H.K., Cobbold, S.P., Waldmann, H., and Metcalfe, S. (1996). Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation, 62(9): 1200-1206.
18. Cho, Y.W., Cecka, J.M., and Terasaki, P.I. (1994). HLA matching effect: better survival rates and graft quality. Clin. Transplant., 435-449.
19. Christopherson, K.W., Hangoc, G., Mantel, C.R., and Broxmeyer, H.E. (2004). Modulation of hematopoietic stem cell homing and engraftment by CD26. Science, 305(5686): 1000-1003.
20. Clift, R.A., and Storb, R. (1987). Histoincompatible bone-marrow transplants in humans. Ann. Rev. Immunol., 5: 43-64.
21. Cooper, D.K.C., Gollackner, B., and Sachs, D.H. (2002). Will the pig solve the transplantation backlog? Annu. Rev. Med., 53: 133-147.
22. Davies, J.D., Martin, G., Phillips, J., Marshall, S.E., Cobbold, S.P., and Waldmann H. (1996). T-cell regulation in adult transplantation tolerance. J. Immunol., 157(2): 529-533.
23. Delenda, C. (2004). Lentiviral vectors: optimization of packaging, transduction and gene expression. J. Gene Med., 6: S125-S138.
24. Delenda, C., and Gaillard, C. (2005). Real-time quantitative PCR for the design of lentiviral vector analytical assays. Gene Ther., 12: S36-S50.
25. Dey, B.R., McAfee, S., Sackstein, R., Colby, C., Saidman, S., Weymouth, D., Polquin, C., Vanderklish, J., Sachs, D.H., Sykes, M., and Spitzer, T,R, (2001). Successful allogeneic stem cell transplantation with non-mycloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation. Biol. Blood Marrow Transplant., 7(11): 604-612.
26. Dunbar, C.E., Takatoku, M., and Donahue, R.E. (2001). The Impact of ex vivo cytokine stimulation on engraftment of primitive hematopoietic cells in a non-human primate model. Ann. N.Y. Acad. Sci., 938: 236-245.
27. Fischer-Lougheed, J.Y., Tarantal, A.F., Shulkin, I., Mitsuhashi, N., Kohn, D.B., Lee, C.C.I., and Keams-Jonker, M. (2007). Gene therapy to inhibit xenoantibody production using lentiviral vectors in non-human primates. Gene Ther., 14(1): 49-57.
28. Forman, D., Tian, C.R., and Iacomini, J. (2005). Induction of donor-specific tolerance in sublethally irradiated recipients by gene therapy. Mol. Ther., 12(2): 353-359.
29. Fudaba, Y., Spitzer, T.R., Shaffer, J., Kawai, T., Fehr, T., Delmonico, F., Preffer, F., Tolkoff-Rubin, N., Dey, B.R., Saidman, S.L., Kraus, A., Bonnefoix, T., McAfee, S., Power, K., Kattlelman, K., Colvin, R.B., Sachs, D.H., Cosimi, A.B. and Sykes, M. (2006). Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: In vivo and in vitro analyses. Am. J. Transplant., 6: 2121-2133.
30. Galili, U., Rachmilewitz, E.A., Peleg, A., and Flechner, I. (1984). A unique natural human IgG antibody with anti-α-galactosyl specificity. J. Exp. Med, 160: 1519-1531.
31. Galili, U., Shohet, S.B., Korbin, E., Stults, C.L.M., and Macher, B.A. (1988a). Man, apes, and old-world monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J. Biol. Chem., 263(33):17755-17762.
32. Galili, U., Mandrell, R.E., Hamadeh, R.M., Shohet, S.B., and Griffiss, J.M. (1988b). Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora. Infect. Immun., 56(7): 1730-1737.
33. Galili, U., (2005). The alpha-gal epitope and the anti-Gal antibody in xenotransplantation and in cancer immunotherapy. Immunol. Cell Biol., 83(6): 674-686.
34. Good, A.H., Cooper, D.K.C., Malcolm, A.J., Ippolito, R.M., Koren, E., Neethling, F.A., Ye, Y., Zuhdi, N., and Lamontange, L.R. (1992). Identification of carbohydrate structures that bind human antiporcine anti-bodies: implications for discordant xenografting in humans. Transplant. Proc., 24(2): 559-562.
35. Goverdhana, S., Puntel, M., Xiong, W., Zirger, J.M., Barcia, C., Curtin, J.F., Soffer, E.B., Mondkar, S., King, G.D., Hu, J., Sciascia, S.A., Candolfi, M., Greengold, D.S., Lowenstein, P.R., and Castro, M.G. (2005). Regulatable gene expression systems for gene therapy applications: Progress and future challenges. Mol. Ther., 12(2): 189-211.
36. Hacein-Bey-Abina, S., Von Kalle, C., Schidt, M., McCormack, M.P., Wulffraat, N., Leboulch, P., Lim, A., Osborne, C.S., Pawliuk, R., Morillon, E., Sorensen, R., Foster, A., Fraser, P., Cohen, J.I., de Saint Basile, G., Alexander, I., Wintergerst, U., Frebourg, T., Aurias, A., Stoppa-Lyonnet, D., Romana, S., Radford-Weiss, L, Gross, F., Valensi, F., Delabesse, E., Macintyre, E., Sigaux, F., Soulier, J., Leiva, L.E., Wissler, M., Prinz, C., Rabbitts, T.H., Le Deist, F., Fischer, A., and Cavazzana-Calvo, M. (2003). LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-XI. Science, 302(5644): 415-419.
37. Hanawa, H., Hematti, P., Keyvanfar, K., Metzger, M.E., Krouse, A., Donahue, R.E., Kepes, S., Gray, J., Dunbar, C.E., Persons, D.A., and Nienhuis, A.W. (2004). Efficient gene transfer into rhesus repopulating hematopoietic stem cells using a simian immunodeficiency virus-based lentiviral vector system. Blood, 103(11): 4062-4069.
38. Heim, D.A., Hanazono, Y., Giri, N., Wu, T., Childs, R., Sellers, S.E., Muul, L., Agricola, B.A., Metzger, M.E., Donahue, R.E., Tisdale, J.F., and Dunbar, C.E. (2000). Introduction of a xenogeneic gene via hematopoietic stem cells leads to specific tolerance in a rhesus monkey model. Mol. Ther., 1(6): 533-544.
39. Hematti, P., Hong, B.K., Ferguson, C., Adler, R., Hanawa, H., Sellers, S., Holt, I.E., Eckfeldt, C.E., Sharma, Y., Schmidt, M., von Kalle, C. Persons, D.A., Billings, E.M., Verfaillie, C.M., Nienhuis, A.W., Wolfsberg, T.G., Dunbar, C.E., and Calmels, B. (2004). Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells. PLoS Biol., 2(12):2183-2190.
40. Holman, A.G., and Coffin J.M. (2005). Symmetrical base preferences surrounding HIV-1, avian sarcoma/leukosis virus, and murine leukemia virus integration sites. Proc. Natl. Acad. Sci. USA., 102(17): 6103-6107.
41. Hom, P.A., Morris, J.C., Neff, T., and Kiem, H.P. (2004). Stem cell gene transfer-efficacy and safety in large animal studies. Mol. Ther., 10(3): 417-431.
42. Ildstad, S.T., and Sachs, D.H. (1984). Reconstitution with syngeneic plus allogeneic or xenogeneic bone marrow leads to specific acceptance of allografts or xenografts. Nature, 307(5947): 168-170.
43. Kang, E.M., Hanazano, Y., Frare, P., Vanin, E.F., De Witte, M., Metzger, M., Liu, J.M., and Tisdale, J.F. (2001). Persistent low-level engraftment of rhesus peripheral blood progenitor cells transduced with the Fanconi anemia C gene after conditioning with low-dose irradiation. Mol. Ther., 3(6): 911-919.
44. Kawai, T., Cosimi, A.B., Colvin, R.B., Powelson, J., Eason, J., Kozlowski, T., Sykes, M., Monroy, R., Tanaka, M., and Sachs, D.H. (1995). Mixed allogeneic chimerism and renal-allograft tolerance in cynomolgus monkeys. Transplantation, 59(2): 256-262.
45. Kawai, T., Sachs, D.H., and Cosimi, A.B. (1999). Tolerance to vascularized organ allografts in large-animal models. Curr. Opin. Immunol., 11(5): 516-520.
46. Kean, L.S., Gangappa, S., Pearson, T.C., and Larsen, C.P. (2006). Transplant tolerance in non-human primates: progress, current challenges and unmet needs. Am. J. Transplant., 6(5): 884-893.
47. Kean, L.S., Adams, A.B., Strobert, E., Hendrix, R., Gangappa, S., Jones, T.R., Shirasugi, N., Rigby, M.R., Hamby, K., Jiang, J., Bello, H., Anderson, D., Cardona, K., Durham, M.M., Pearson, T.C., and Larsen, C,P. (2007). Induction of chimerism in rhesus macaques through stem cell transplant and costimulation blockade-based immunosuppression. Am. J. Transplant., 7: 320-335.
48. Keams-Jonker, M., Fischer-Lougheed, J., Shulkin, I., Kleihauer, A., Mitsuhashi, N., Kohn, D.B., Weinberg, K., D'Apice, A.J.F., Starnes, V.A., and Cramer, D.V. (2004). Use of lentiviral vectors to induce long-term tolerance to Gal(+). heart grafts. Transplantation, 77(11): 1748-1754.
49. Kim, H.J., Tisdale, J.F., Wu, T., Takatoku, M., Sellers, S.E., Zickler, P., Metzger, M.E., Agricola, B.A., Malley, J.D., Kato, I., Donahue, R.E., Brown, K.E., and Dunbar, C.E. (2000). Many multipotential gene-marked progenitor or stem cell clones contribute to hematopoiesis in nonhuman primates. Blood, 96(1): 1-8.
50. Kluge, K.A., Bonifacino, A.C., Sellers, S., Agricola, B.A., Donahue, R.E., and Dunbar, C.E. (2002). Retroviral transduction and engraftment ability of primate hematopoietic progenitor and stem cells transduced under serum-free versus serum-containing conditions. Mol. Ther., 5(3): 316-322.
51. Kondo, E., Akatsuka, Y., Nawa, A., Kuzushima, K., Tsujimura, K., Tanimoto, M., Kodera, Y., Morishima, Y., Kuzuya, K., and Takahashi, T. (2005). Retroviral vector backbone immunogenicity: identification of cytotoxic T-cell epitopes in retroviral vector-packaging sequences. Gene Ther., 12(3): 252-258.
52. Kootstra, N.A., and Verma, I.M. (2003). Gene thei -y with viral vectors. Annu. Rev. Pharmacol. Toxicol., 43: 413-439.
53. Koyama, I., Nadazdin, O., Boskovic, S., Ochiai, T., Smith, R.N., Sykes, M., Sogawa, H., Murakami, T., Strom, T.B., Colvin, R.B., Sachs, D.H., Benichou, G., Cosimi, A.B., and Kawai, T. (2007). Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft. Am. J. Transplant., 7: 1055-1061.
54. Kung, S.K.P., Bonifacino, A., Metzger, M.E., Ringpis, G.E., Donahue, R.E., and Chen, I.S.Y (2005). Lentiviral vector-transduced dendritic cells induce specific T cell response in a nonhuman primate model. Hum. Gene. Ther., 16(4): 527-532.
55. Kurre, P., Anandakumar, P., and Kiem, H. P. (2006). Rapid 1-hour transduction of whole bone marrow leads to long-term repopulation of murine recipients with lentivirus-modified hematopoietic stem cells. Gene Ther., 13(4): 369-373.
56. Kustikova, O.S., Wahlers, A., Kühlcke, K., Stähle, B., Zander, A.R., Baum, C., and Fehse, B. (2003). Dose finding with retroviral vectors: correlation of retroviral vector copy numbers in single cells with gene transfer efficiency in a cell population. Blood, 102(12): 3934-3937.
57. LaTemple, D.C., and Galili, U. (1998). Adult and neonatal anti-Gal response in knock-out mice for alpha 1,3galactosyltransferase. Xenotransplantation, 5(3): 191-196.
58. Levine, B.L., Humeau, L.M., Boyer, J., MacGregor, R.R., Rebello, T., Lu, X., Binder, G.K., Slepushkin, V., Lemiale, F., Mascola, J.R., Bushman, F.D., Dropulic, B., and June, C.H. (2006). Gene transfer in humans using a conditionally replicating lentiviral vector. Proc. Natl. Acad. Sci. USA, 103(46). 17372-17377.
59. Logan, A.C., Lutzko, C., and Kohn, D.B. (2002). Advances in lentiviral vector design for gene-modification of hematopoietic stem cells. Curr. Opin. Biotechnol., 13(5): 429-436.
60. Marcén, R., Morales, J.M., Arias, M., Fernández-Juárez, G., Fernández-Fresnedo, G., Andrés, A., Rodrigo, E., Pascual, J., Domínguez, B., and Ortuño, J. (2006). Ischemic heart disease after renal transplantation in patients on cyclosporine in Spain. J. Am. Soc. Nephrol., 17: S286-S290.
61. Maxfield, L.F., Fraize, C.D., and Coffin, J.M. (2005). Relationship between retroviral DNA-integration-site selection and host cell transcription. Proc. Natl. Acad. Sci. USA, 102(5): 1436-1441.
62. Mitchell, R.S., Beitzel, B.F., Schroder, A.R.W., Shinn, P., Chen, H., Berry, C.C., Ecker, JR., and Bushman, F.D. (2004). Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences. PLoS Biol., 2(8): 1127-1137.
63. Mitsubashi, N., Fischer-Lougheed, J., Shulkin, I., Kleihauer, A., Kohn, D.B., Weinberg, K.I., Stames, V.A., and Keams-Jonker, M. (2006). Tolerance induction by lentiviral gene therapy with a nonmyeloablative regimen. Blood, 107(6): 2286-2293.
64. Montini, E., Cesana, D., Schmidt, M., Sanvito, F., Ponzoni, M., Bartholomae, C., Sergi, L.S.,-Benedicenti, F., Ambrosi, A., Di Serio, C., Doglioni, C., von Kalle, C., and Naldini, L. (2006). Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration. Nat. Biotechnol., 24(6): 687-696.
65. Mostoslavsky, G., Kotton, D.N., Fabian, A.J., Gray, J.T., Lee, J.S., and Mulligan, R.C. (2005). Efficiency of transduction of highly purified murine hematopoietic stem cells by lentiviral and oncoretroviral vectors under conditions of minimal in vitro manipulation. Mol. Ther., 11(6): 932-940.
66. Nienhuis, AW., Dunbar, C.E., and Sorrentino, B.P. (2006). Genotoxicity of retroviral integration in hematopoietic cells. Mol. Ther., 13(6): 1031-1049.
67. Ohdan, H., Yang, Y.G., Shimizu, A., Swenson, K.G., and Sykes, M. (1999). Mixed chimerism induced without lethal conditioning prevents T cell and anti-Gal alpha 1,3Gal-mediated graft rejection. J. Clin. Invest., 104(3): 281-290.
68. Ohdan, H., Swenson, K.G., Kitamura, H., Yang, Y.G., and Sykes, M. (2001). Tolerization of Gal alpha 1,3Gal-reactive B cells in presensitized alpha 1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism. Xenotransplantation, 8(4): 227-238.
69. Ohdan, H., and Sykes, M. (2003). B cell tolerance to xenoantigens. Xenotransplantation, 10(2): 98-106.
70. Owen, R.D. (1945). Immunogenetic consequences of vascular anastomoses between bovine twins. Science, 102(2651): 400-401.
71. Parkman, R., and Weinberg K.I. (1997). Immunological reconstitution following bone marrow transplantation. Immunol. Rev., 157: 73-78.
72. Penn, I. (1998). Occurrence of cancers in immunosuppressed organ transplant recipients. Clin. Transpl., 147-150.
73. Piacibello, W., Bruno, S., Sanavio, F., Droetto, S., Gunetti, M., Ailles, L., Santom de Sio, F.R, Viale, A., Gammaitoni, L., Lombardo, A., Naldini, L., and Aglietta, M. (2002). Lentiviral gene transfer and ex vivo expansion of human primitive stem cells capable of primary, secondary, and tertiary multilineage repopulation in NOD/SCID mice. Blood, 100(13): 4391-4400.
74. Pluta, K., Luce, M.J., Bao, L., Agha-Mohammadi, S., and Reiser, J. (2005). Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters. J. Gene Med., 7(6): 803-817.
75. Rabbitts, T.H., Bucher, K., Chung, G., Grutz, G., Warren, A., and Yamada, Y. (1999). The effect of chromosomal translocations in acute leukemias: The LMO2 paradigm in transcription and development. Cancer Res., 59(7): 1794S-1798S.
76. Recillas-Targa, F., Valadez-Graham, V., and Farrell, C.M. (2004). Prospects and implications of using chromatin insulators in gene therapy and transgenesis. Bioessays, 26(7): 796-807.
77. Reiser, J., Lai, Z., Zhang, X.Y., and Brady, R.O. (2000). Development of multigene and regulated lentivirus vectors. J. Virol., 74(22): 10589-10599.
78. Rohdewohld, H., Weiher, H., Reik, W., Jaenisch, R., and Breindl, M. (1987). Retrovirus integration and chromatin structure - Moloney murine leukemia proviral integration sites map near DNAse I-hypersensitive sites. J. Virol., 61(2): 336-343.
79. Rosengard, BR., Ojikutu, C.A., Fishbein, J., Kortz, E.O., and Sachs, D.H. (1992). Selective breeding of miniature swine leads to an increased rate of acceptance of MHC-identical, but not of class I-disparate, renal allografts. J. Immunol., 149(3): 1099-1103.
80. Rosenzweig, M., MacVittie, T.J., Harper, D., Hempel, D., Glickman, R.L., Johnson, R.P., Farese, A.M., Whiting-Theobald, N., Linton, G,F., Yamasaki, G., Jordan, C.T., and Malech, H.L. (1999). Efficient and durable gene marking of hematopoietic progenitor cells in nonhuman primates after nonablative conditioning. Blood, 94(7): 2271-2286.
81. Sachs, D.H. (1994). The pig as a potential xenograft donor. Vet. Immunol. Immunopathol., 43(1-3): 185-191.
82. Sandrin, V., Boson, B., Salmon, P., Gay, W., Negre, D., Le Grand, R., Trono, D., and Cosset, F.L. (2002). Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34(-). cells derived from human and nonhuman primates. Blood, 100(3): 823-832.
83. Santoni de Sio, F.R., Cascio, P., Zingale, A., Gasparini, M., and Naldini, L. (2006). Proteasome activity restricts lentiviral gene transfer into hematopoietic stem cells and is down-regulated by cytokines that enhance transduction. Blood, 107(11): 4257-4265.
84. Shaw, L.M., Kaplan, B., and Kaufman, D. (1996). Toxic effects of immunosuppressive drugs: mechanisms and strategies for controlling them. Clin. Chem., 42(8): 1316-1321.
85. Sonntag, K.C., Emery, D.W., Yasumoto, A., Haller, G., Germana, S., Sablinski, T., Shimizu, A., Yamada, K.; Shimada, H., Am, S., Sachs, D.H., and LeGuem, C. (2001). Tolerance to solid organ transplants through transfer of'MHC class II genes. J. Clin. Invest., 107(1): 65-71.
86. Spitzer, T.R., Delmonico, F., Tolkoff-Rubin, N., McAfee, S., Sackstein, R., Saidman, S., Colby, C., Sykes, M., Sachs, D.H., and Cosimi, A.B. (1999). Combined histocompatibility leukocyte anfigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: The induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation, 68(4): 480-484.
87. Sundt, T.M., and Sachs, D.H. (1988). Applications of molecular biology to transplantation tolerance. Immunol. Today, 9(11): 342-344.
88. Sykes, M., Sachs, D.H., Nienhuis, AW., Pearson, D.A., Moulton, A.D., and Bodine, D.M. (1993). Specific prolongation of skin graft survival following retroviral transduction of bone marrow with allogeneic major histocompatibility complex gene. Transplantation, 55(1): 197-202.
89. Sykes, M. (1996). Chimerism and central tolerance. Curr. Opin. Immunol., 8(5): 694-703.
90. Sykes, M., Preffer, F., McAfee, S., Saidman, S.L., Weymouth, D., Andrews, D.M., Colby, C., Sackstein, R., Sachs, D.H., and Spitzer, T.R. (1999). Mixed lymphohametopoietic chimerism and graft-versus-lymphoma effects after non-myeloablafive therapy and HLA-mismatched bonemarrow transplantation. Lancet, 353(9166): 1755-1759.
91. Sykes, M. (2001). Mixed chimerism and transplant tolerance. Immunity, 14(4): 417-424.
92. Tearle, R.G Tange, M.J., Zannettino, Z.L., Katerelos, M., Shinkel, T.A., vanDenderen, B.J.W., Lonie, A.J., Lyons, I., Nottle, M.B., Cox, T., Becker, C., Peura, A.M., Wigley, P,L., Crawford R.J., Robins, A.J., Pearse, M.J., and D'Apice, A.J.F. (1996). The alpha-1,3-galactosyl- transferase knockout mouse - Implications for xenotransplantation. Transplantation, 61(1): 13-19.
93. Thall, A.D., Murphy, H.S., and Lowe, J.B. (1996). Alpha 1,3-Galactosyltransferase-deficient mice produce naturally occurring cytotoxic anti-Gal antibodies. Transplant. Proc., 28(2): 556-557.
94. Tian, C., Bagley, J., Forman, D., and Iacomini, J. (2006). Inhibition of CD26 peptidase activity significantly improves engraftment of retrovirally transduced hematopoietic progenitors. Gene Ther., 13(7): 652-658.
95. Tomita, Y., Khan, A., and Sykes, M. (1994). Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone-marrow transplantation in mice conditioned with a nonmyeloablative regimen. J. Immunol., 153(3): 1087-1098.
96. Tseng, Y.L., Sachs, D.H., and Cooper, D.K.C. (2005). Porcine hematopoietic progenitor cell transplantation in nonhuman primates: a review of progress. Transplantation, 79(1): 1-9.
97. Wekerle T., Sykes M. (2004). Induction of tolerance. Surgery, 135(4): 359-364.
98. Wekerle T., Sykes M. (2001). Mixed chimerism and transplantation tolerance. Annu. Rev. Med., 52: 353-370.
99. Wong, W., Morris, P.J., and Wood, K.J. (1997). Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts - Evidence for linked epitope suppression. Transplantation, 63(10): 1490-1494.
100. Wong, W., Billings, J.S., Stranford, S.A., Hyde, K., Fry, J., Morris, P.J., and Wood, K.J. (2003). Retroviral transfer of donor MHC class I or MHC class II genes into recipient bone marrow cells can induce operational tolerance to alloantigens in vivo. Hum. Gene Ther., 14(6): 577-590.
101. Wong, W. and Wood, K.J. (2004). Transplantation tolerance by donor MHC gene transfer. Curr. Gene Ther., 4(3): 329-336.
102. Wood, K.J. (1997). Gene therapy and allotransplantation. Curr. Opin. Immunol., 9(5): 662-668.
103. Wu, X., Li, Y., Crise, B., and Burgess, S.M. (2003). Transcription start regions in the human genome are favored targets for MLV integration. Science, 300(5626): 1749-1751.
104. Yam P.Y., Li, S.L., Wu, J., Hu, J., Zaia, J.A., and Yee, J.K. (2002). Design of HIV vectors for efficient gene delivery into human hematopoietic, cells. Mol. Ther., 5(4): 479-484.
105. Yang, Y.G., deGoma, E., Ohdan, H., Bracy, J.L., Xu, Y., lacomini, J., Thall, A.D., and Skykes, M. (1998). Tolerization of anti-Gal alpha 1-3Gal natural antibody-forming B cells by induction of mixed chimerism. J. Exp. Med., 187(8): 1335-1342.
106. Young, L.S., Searle, P.F., Onion, D., and Mautner, V. (2006). Viral gene therapy strategies: from basic science to clinical application. J. Pathol., 208(2): 299-318.
107. Zhang, J.L., Cai, J., Jackson, J.D., Kuszynski, C.A., Walls, S., Mclvor, R.S., and Fox, I.J. (2005a). Long-term transgene expression and survival of transgene-expressing grafts following lentivirus transduction of bone marrow side population cells. Transplantation, 79(8): 882-888.
108. Zhang, J.L., Cai, J., Jackson, J.D., Walls, S., Kuszynski, C.A., and Fox, I.J. (2005b). Competitive equality of donor cells expressing a disparate MHC antigen following stem cell-enriched bone marrow transplantation. Transplantation, 79(10): 1332-1337.
109. Zhang, J.L., Cai, J., Walls, S., Jackson, J.D., Kuszynski, C.A., Zhao, Y., Pawliuk, R., Leboulch, P., and Fox, I.J. (2005c). Tolerance by selective in vivo expansion of foreign major histocompatibility complex-transduced autologous bone marrow. Transplantation, 80(3): 362-369.